Cancer
INDICATION: Cancer; colorectal cancer; cutaneous T cell lymphoma (CTCL)
In vitro and cell culture studies identified agonists of RXR heterodimerization that could help treat colorectal cancer, CTCL and other cancers without causing the metabolic and cutaneous...
